Indications
Sabervel is indicated in adults for the treatment of essential hypertension. It is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.
Composition
- Active substance
- irbesartan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Sabervel
- Active substance
- irbesartan
- ATC code
- C09CA04
- Therapeutic area
- Hypertension
- Marketing authorisation holder
- Pharmathen S.A.
- Status
- Expired